Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study

dc.contributor.authorBremer, Birgit
dc.contributor.authorAnastasiou, Olympia
dc.contributor.authorHardtke, Svenja
dc.contributor.authorCaruntu, Florin Alexandru
dc.contributor.authorCurescu, Manuela Gabriela
dc.contributor.authorYalcin, Kendal
dc.contributor.authorAkarca, Ulus S.
dc.date.accessioned2024-04-24T17:49:59Z
dc.date.available2024-04-24T17:49:59Z
dc.date.issued2020
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS868en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS868en_US
dc.identifier.urihttps://hdl.handle.net/11468/23142
dc.identifier.volume73en_US
dc.identifier.wosWOS:000786587002509
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleResidual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II studyen_US
dc.titleResidual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study
dc.typeConference Objecten_US

Dosyalar